Find Drugs for Trauma (Emergency, Injury, Surgery) in Phase III Clinical Development in GERMANY

Lead Product(s): Ronopterin

Therapeutic Area: Trauma (Emergency, Injury, Surgery)

Highest Development Status: Phase III Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 29, 2020

Details:

NOSTRA III is a 220 patient Phase III clinical trial assessing efficacy and safety of Ronopternin (VAS203) for the treatment of moderately to severely injured closed head traumatic brain injuries.